Evidence map›Paper›PMID 41183009›Full record

ArticleEnvironmental science & technology2025

Lifetime Swimming Pool Attendance and Cancer Risk: Findings from the Multicase-Control Study in Spain (MCC-Spain).

Carolina Donat-Vargas, Miquel Vallbona-Vistós, Gemma Castaño-Vinyals, Víctor Moreno, Nuria Aragonés, Elena Boldo, Antonio José Molina de la Torre, Inés Gómez-Acebo, Marcela Guevara, Ana Jiménez Zabala and 7 more

Abstract read
In one paragraph

Article in Environmental science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Carolina Donat-VargasISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.
Miquel Vallbona-VistósISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.
Gemma Castaño-VinyalsISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.
Víctor MorenoCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Nuria AragonésCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Elena BoldoCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Antonio José Molina de la TorreCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Inés Gómez-AceboCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Marcela GuevaraCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Ana Jiménez ZabalaPublic Health Division of Gipuzkoa, Biogipuzkoa Research Institute, Av. Navarra 4, 20013 San Sebastian, Spain.
Pilar AmianoCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Ana Molina-BarcelóCancer and Public Health Area, Foundation for the Promotion of Health and Biomedical Research-Public Health Research (FISABIO), Avda. de Catalunya 21, 46020 Valencia, Spain.
Guillermo Fernández-TardónCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Maria Dolores ChirlaqueCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Marina PollánCIBER de Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III, Av. Monforte de Lemos, 3-5, Pabellón 11, 28029 Madrid, Spain.
Manolis KogevinasISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.
Cristina M VillanuevaISGlobal, Doctor Aiguader 88, 08003 Barcelona, Spain.ORCID 0000-0002-0783-1259

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Swimming in pools involves inhalation and skin absorption of potential carcinogenic disinfection byproducts (DBPs) as well as physical activity, which is protective for some cancer sites. We evaluated the association between lifetime pool attendance and the risk of breast, colorectal, and prostate cancer in a multicase-control study that recruited 4,941 hospital-based cancer cases (1,724 breast, 2,111 colorectal, 1,106 prostate) and 4,039 population-based controls in Spain (2008-2013). Lifetime swimming pool attendance in summer (as a surrogate of outdoor pools) and the rest of the year (as a surrogate of indoor pools), socio-demographics, and lifestyle were ascertained in face-to-face interviews. Cancer risk associated with pool attendance markers was estimated using linear mixed-effect models, adjusting for covariates with recruitment area as a random effect. Participants reporting lifetime pool attendance compared to those who did not showed lower odds of breast and colorectal cancer (approximately 5% lower risk). Swimming more than 10 times/month did not increase the protective association. For breast and colorectal cancer, only pool attendance outside the summer months was associated with a lower risk, whereas it was associated with increased prostate cancer risk. Findings suggest that lifetime swimming in pools may reduce breast cancer and colorectal cancer risk despite DBP exposure. These novel findings require replication.

Indexed as

NeoplasmsSwimming PoolsAdultAgedBreast NeoplasmsCase-Control StudiesColorectal NeoplasmsFemaleHumansMaleMiddle AgedProstatic NeoplasmsRisk FactorsSpainSwimmingbreast cancercase-control studycolorectal cancerDisinfection byproductsenvironmental epidemiologyobservational studyprostate cancerswimming pool

Identifiers

PMID41183009
PMCPMC12631987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.